This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mutter, G. L. Articles by Fletcher, J. A. Search for Related Content PubMed PubMed Citation Articles by Mutter, G. L. Articles by Fletcher, J. A.

American Journal of Pathology, Vol 146, 501-508, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers

GL Mutter, ML Chaponot and JA Fletcher
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115.

We hypothesize that endometrial carcinoma and their precursors share a monoclonal growth pattern and tested this thesis with archival paraffin- embedded tissues using a polymerase chain reaction-based assay for non- random X chromosome inactivation. Of the 10 well-differentiated endometrial adenocarcinoma cases with heterozygous markers (HUMARA, X- linked androgen receptor gene), 9 had skewed X inactivation consistent with a monoclonal process, and one contained a structurally altered HUMARA gene. X inactivation skewing similar to that of the tumor was seen in matched control polyclonal tissues of 4 (of 9) cases, caused by the small number of endometrial stem cells at the time of embryonic X inactivation. When the polymerase chain reaction assay was applied to four potential endometrial precancers (atypical endometrial hyperplasia) and matched control tissues, two were inconclusive, and two were found to be monoclonal. We conclude that 1) it is essential to include polyclonal control tissues in X inactivation analyses to determine whether skewing is a specific indicator of monoclonality; and 2) endometrial adenocarcinomas and some putative precancers, atypical endometrial hyperplasia, are monoclonal.

This article has been cited by other articles:

				A. Pandita, A. Balasubramaniam, R. Perrin, P. Shannon, and A. Guha Malignant and benign ganglioglioma: A pathological and molecular study Neuro-oncol, April 1, 2007; 9(2): 124 - 134. [Abstract] [Full Text] [PDF]

				J. L. Hecht and G. L. Mutter Molecular and Pathologic Aspects of Endometrial Carcinogenesis J. Clin. Oncol., October 10, 2006; 24(29): 4783 - 4791. [Abstract] [Full Text] [PDF]

				J P A Baak and G L Mutter EIN and WHO94 J. Clin. Pathol., January 1, 2005; 58(1): 1 - 6. [Full Text] [PDF]

				M. Tanaka, S. Kyo, T. Kanaya, N. Yatabe, M. Nakamura, Y. Maida, M. Okabe, and M. Inoue Evidence of the Monoclonal Composition of Human Endometrial Epithelial Glands and Mosaic Pattern of Clonal Distribution in Luminal Epithelium Am. J. Pathol., July 1, 2003; 163(1): 295 - 301. [Abstract] [Full Text] [PDF]

				A. Fusco, G. Chiappetta, P. Hui, G. Garcia-Rostan, L. Golden, B. K. Kinder, D. A. Dillon, A. Giuliano, A. M. Cirafici, M. Santoro, et al. Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma : A Search for the Early Precursors of Papillary Cancer Am. J. Pathol., June 1, 2002; 160(6): 2157 - 2167. [Abstract] [Full Text] [PDF]

				G L Mutter Diagnosis of premalignant endometrial disease J. Clin. Pathol., May 1, 2002; 55(5): 326 - 331. [Abstract] [Full Text] [PDF]

				J. O. Indsto, A. R. Cachia, R. F. Kefford, and G. J. Mann X Inactivation, DNA Deletion, and Microsatellite Instability in Common Acquired Melanocytic Nevi Clin. Cancer Res., December 1, 2001; 7(12): 4054 - 4059. [Abstract] [Full Text] [PDF]

				S. J. Diaz-Cano, M. de Miguel, A. Blanes, R. Tashjian, and H. J. Wolfe Germline RET 634 Mutation Positive MEN 2A-related C-Cell Hyperplasias Have Genetic Features Consistent with Intraepithelial Neoplasia J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3948 - 3957. [Abstract] [Full Text] [PDF]

				A. W. Ferguson, H. Katabuchi, B. M. Ronnett, and K. R. Cho Glial Implants in Gliomatosis Peritonei Arise from Normal Tissue, Not from the Associated Teratoma Am. J. Pathol., July 1, 2001; 159(1): 51 - 55. [Abstract] [Full Text] [PDF]

				V. Mahavni, S. C Kim, T. A Benda, L. Sanders, and R. E Buller The androgen receptor and DXS15-134 markers show a high rate of discordance for germline X chromosome inactivation J. Med. Genet., July 1, 2001; 38(7): 474 - 478. [Full Text]

				G. L. Mutter, M.-C. Lin, J. T. Fitzgerald, J. B. Kum, J. P. A. Baak, J. A. Lees, L.-P. Weng, and C. Eng Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers J Natl Cancer Inst, June 7, 2000; 92(11): 924 - 930. [Abstract] [Full Text] [PDF]

				S. J. Diaz-Cano, M. de Miguel, A. Blanes, R. Tashjian, H. Galera, and H. J. Wolfe Clonality as Expression of Distinctive Cell Kinetics Patterns in Nodular Hyperplasias and Adenomas of the Adrenal Cortex Am. J. Pathol., January 1, 2000; 156(1): 311 - 319. [Abstract] [Full Text] [PDF]

				R. E. Buller, A. K. Sood, T. Lallas, T. Buekers, and J. S. Skilling Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer J Natl Cancer Inst, February 17, 1999; 91(4): 339 - 346. [Abstract] [Full Text] [PDF]